Pharmacological HDAC inhibition impairs pancreatic ß-cell function through an epigenome-wide reprogramming (2023)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.isci.2023.107231
PubMed Identifier: 37496675
Publication URI: http://europepmc.org/abstract/MED/37496675
Type: Journal Article/Review
Parent Publication: iScience
Issue: 7
ISSN: 2589-0042